Stocktoria

Xencor Inc XNCR

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2013-12-03 · LEI

Xencor Inc financials (annual)

Revenue
$109.0M $46.1M $40.6M $156.7M $122.7M $275.1M $164.6M $174.6M $110.5M $125.6M 2016201720182019202020212022202320242025
Net income
$45.1M -$38.5M -$70.4M $26.9M -$69.3M $82.6M -$55.2M -$133.1M -$232.6M -$91.9M 2016201720182019202020212022202320242025
Free cash flow
$93.7M -$38.9M -$87.0M $57.0M -$15.5M -$30.2M -$14.0M -$96.4M -$208.3M -$138.3M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$125.6M$110.5M$174.6M$164.6M$275.1M$122.7M$156.7M$40.6M$46.1M$109.0M
R&D expense$239.4M$227.7M$253.6M$199.6M$192.5M$169.8M$118.6M$97.5M$71.8M$51.9M
Operating income-$177.5M-$178.4M-$132.4M-$82.5M$43.8M-$76.8M$13.8M-$79.4M-$43.1M$44.0M
Interest expense$16,000$13,000$21,000
Income tax$2.5M$1.6M$13.7M$673,000$0$0$312,000$0-$463,000$991,000
Net income-$91.9M-$232.6M-$133.1M-$55.2M$82.6M-$69.3M$26.9M-$70.4M-$38.5M$45.1M
EPS (diluted)$-1.24$-3.58$-2.20$-0.93$1.37$-1.21$0.46$-1.31$-0.82$1.07
Operating cash flow-$135.1M-$202.2M-$77.9M$24.5M-$16.9M-$5.0M$64.4M-$79.8M-$33.6M$95.2M
Free cash flow-$138.3M-$208.3M-$96.4M-$14.0M-$30.2M-$15.5M$57.0M-$87.0M-$38.9M$93.7M
Cash & equivalents$54.1M$40.9M$53.8M$53.9M$143.5M$163.5M$50.3M$26.2M$16.5M$14.5M
Total assets$875.5M$951.9M$965.1M$846.3M$838.2M$703.2M$670.2M$576.7M$390.2M$428.6M
Total liabilities$239.9M$277.9M$303.0M$118.8M$104.7M$130.8M$77.0M$55.1M$73.7M$114.6M
Shareholders' equity$635.6M$677.6M$662.1M$727.5M$733.5M$572.4M$593.2M$521.7M$316.5M$337.9M

Growth · year-over-year · Revenue CAGR 1.6%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+13.7%-36.7%+6.1%-40.2%+124.2%-21.7%+285.9%-12.0%-57.7%
Net income growth-166.8%-358.0%-185.3%
EPS growth-167.9%-363.0%-176.6%
Free cash flow growth-127.3%-141.5%+278.9%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.